These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8654564)

  • 21. Crystal structure of the major histocompatibility complex class I H-2Kb molecule containing a single viral peptide: implications for peptide binding and T-cell receptor recognition.
    Zhang W; Young AC; Imarai M; Nathenson SG; Sacchettini JC
    Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8403-7. PubMed ID: 1325657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conversion of a self peptide sequence into a Kd-restricted neo-antigen by a Tyr substitution.
    Healy F; Drouet C; Romero P; Jaulin C; Maryanski JL
    J Exp Med; 1991 Dec; 174(6):1657-60. PubMed ID: 1744590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced intracellular dissociation of major histocompatibility complex class I-associated peptides: a mechanism for optimizing the spectrum of cell surface-presented cytotoxic T lymphocyte epitopes.
    Sijts AJ; Pamer EG
    J Exp Med; 1997 Apr; 185(8):1403-11. PubMed ID: 9126921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peptide loading of empty major histocompatibility complex molecules on RMA-S cells allows the induction of primary cytotoxic T lymphocyte responses.
    De Bruijn ML; Schumacher TN; Nieland JD; Ploegh HL; Kast WM; Melief CJ
    Eur J Immunol; 1991 Dec; 21(12):2963-70. PubMed ID: 1660811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endogenous presentation of a nascent antigenic epitope to CD8+ CTL is more efficient than exogenous presentation.
    Hahn YS; Hahn CS; Braciale TJ
    Immunol Cell Biol; 1996 Oct; 74(5):394-400. PubMed ID: 8912001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules.
    Shirai M; Pendleton CD; Berzofsky JA
    J Immunol; 1992 Mar; 148(6):1657-67. PubMed ID: 1371784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T cell receptor (TCR) recognition of MHC class I variants: intermolecular second-site reversion provides evidence for peptide/MHC conformational variation.
    Dyall R; Fremont DH; Jameson SC; Nikolić-Zugić J
    J Exp Med; 1996 Jul; 184(1):253-8. PubMed ID: 8691139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of epitope modification on T cell receptor-ligand binding and antigen recognition by seven H-2Kd-restricted cytotoxic T lymphocyte clones specific for a photoreactive peptide derivative.
    Kessler BM; Bassanini P; Cerottini JC; Luescher IF
    J Exp Med; 1997 Feb; 185(4):629-40. PubMed ID: 9034142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytotoxic T lymphocyte responses to wild-type and mutant mouse p53 peptides.
    Bertholet S; Iggo R; Corradin G
    Eur J Immunol; 1997 Mar; 27(3):798-801. PubMed ID: 9079825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Most residues on the floor of the antigen binding site of the class I MHC molecule H-2Kd influence peptide presentation.
    Jaulin C; Romero P; Luescher IF; Casanova JL; Prochnicka-Chalufour A; Langlade-Demoyen P; Maryanski JL; Kourilsky P
    Int Immunol; 1992 Aug; 4(8):945-53. PubMed ID: 1358191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vesicular stomatitis virus antigenic octapeptide N52-59 is anchored into the groove of the H-2Kb molecule by the side chains of three amino acids and the main-chain atoms of the amino terminus.
    Shibata K; Imarai M; van Bleek GM; Joyce S; Nathenson SG
    Proc Natl Acad Sci U S A; 1992 Apr; 89(7):3135-9. PubMed ID: 1313583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Self peptides isolated from MHC glycoproteins of non-obese diabetic mice.
    Reich EP; von Grafenstein H; Barlow A; Swenson KE; Williams K; Janeway CA
    J Immunol; 1994 Mar; 152(5):2279-88. PubMed ID: 8133041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The structural basis of MHC control of collagen-induced arthritis; binding of the immunodominant type II collagen 256-270 glycopeptide to H-2Aq and H-2Ap molecules.
    Kjellén P; Brunsberg U; Broddefalk J; Hansen B; Vestberg M; Ivarsson I; Engström A; Svejgaard A; Kihlberg J; Fugger L; Holmdahl R
    Eur J Immunol; 1998 Feb; 28(2):755-67. PubMed ID: 9521085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peptide affinity for MHC influences the phenotype of CD8(+) T cells primed in vivo.
    Ma H; Kapp JA
    Cell Immunol; 2001 Nov; 214(1):89-96. PubMed ID: 11902833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibodies directed against the MHC-I molecule H-2Dd complexed with an antigenic peptide: similarities to a T cell receptor with the same specificity.
    Polakova K; Plaksin D; Chung DH; Belyakov IM; Berzofsky JA; Margulies DH
    J Immunol; 2000 Nov; 165(10):5703-12. PubMed ID: 11067928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of antigenic peptides with MHC class I molecules on living cells studied by photoaffinity labeling.
    Luescher IF; Lóez JA; Malissen B; Cerottini JC
    J Immunol; 1992 Feb; 148(4):1003-11. PubMed ID: 1737923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A molecular basis for how a single TCR interfaces multiple ligands.
    Boesteanu A; Brehm M; Mylin LM; Christianson GJ; Tevethia SS; Roopenian DC; Joyce S
    J Immunol; 1998 Nov; 161(9):4719-27. PubMed ID: 9794402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of antigen-specific cytotoxic T lymphocytes by beta 2-microglobulin or TAP1 gene disruption and the introduction of recipient-matched MHC class I gene in allogeneic embryonic stem cell-derived dendritic cells.
    Matsunaga Y; Fukuma D; Hirata S; Fukushima S; Haruta M; Ikeda T; Negishi I; Nishimura Y; Senju S
    J Immunol; 2008 Nov; 181(9):6635-43. PubMed ID: 18941254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of overlapping epitopes in mutant ras oncogene peptides that activate CD4+ and CD8+ T cell responses.
    Abrams SI; Stanziale SF; Lunin SD; Zaremba S; Schlom J
    Eur J Immunol; 1996 Feb; 26(2):435-43. PubMed ID: 8617315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T cell recognition of an engineered MHC class I molecule: implications for peptide-independent alloreactivity.
    Janković V; Remus K; Molano A; Nikolich-Zugich J
    J Immunol; 2002 Aug; 169(4):1887-92. PubMed ID: 12165513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.